FBXO32 and cancer: In our in vitro and in vivo studies, we showed partially corrected expression of the E3 ligases Atrogin-1 and Murf1 upon MitoQ administration, suggesting that this could be one of the mechanisms of action by which the mitochondrial antioxidant preserves muscle mass in cancer.